Wonder if this would work after T-DxD.
https://www.astrazeneca.com/media-ce...st-cancer.html
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive, HER2-low or negative metastatic breast cancer